Zai Lab Limited ADR [ZLAB] stock is trading at $34.00, up 7.15%. An important factor to consider is whether the stock is rising or falling in short-term value. The ZLAB shares have gain 0.27% over the last week, with a monthly amount glided 25.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on March 03, 2025, when BofA Securities downgraded its rating to a Neutral and also boosted its price target to $36.10 from $29. Previously, Morgan Stanley started tracking the stock with Overweight rating on December 14, 2023, and set its price target to $47.50. On August 10, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $70 on the stock. Macquarie started tracking the stock assigning a Outperform rating and suggested a price target of $64 on January 21, 2022. Bernstein initiated its recommendation with a Mkt Perform. In a note dated April 15, 2020, Guggenheim initiated an Buy rating and provided a target price of $75 on this stock.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $13.48 and $36.60 over the past year. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $34.00 at the most recent close of the market. An investor can expect a potential return of 47.06% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 398.99M for the trailing twelve months, which represents a growth of 65.68%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.64%, and Net Profit Margin reading is -0.64%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.35 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.35 points at the first support level, and at 30.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.87, and for the 2nd resistance point, it is at 35.73.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 3.51. On the other hand, the Quick Ratio is 3.38, and the Cash Ratio is 1.5. Considering the valuation of this stock, the price to sales ratio is 9.30, the price to book ratio is 4.36.
Transactions by insiders
Recent insider trading involved Edmondson Frazor Titus III, Chief Legal Officer, that happened on Feb 28 ’25 when 14544.0 shares were sold. Director, Lis William completed a deal on Feb 28 ’25 to sell 15000.0 shares. Meanwhile, Chairperson & CEO Du Ying sold 50000.0 shares on Feb 28 ’25.
